Pure Global

Individualized Elective Neck Irradiation in NPC Patients - Trial NCT06241612

Access comprehensive clinical trial information for NCT06241612 through Pure Global AI's free database. This Phase 3 trial is sponsored by Sun Yat-sen University and is currently Not yet recruiting. The study focuses on Nasopharyngeal Carcinoma. Target enrollment is 550 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06241612
Phase 3
Not yet recruiting
radiation
Trial Details
ClinicalTrials.gov โ€ข NCT06241612
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Individualized Elective Neck Irradiation in NPC Patients
Individualized Elective Neck Irradiation Based on the Lymph Node Metastasis Pattern in NPC Patients

Study Focus

Nasopharyngeal Carcinoma

Individualized Elective Neck Irradiation

Interventional

radiation

Sponsor & Location

Sun Yat-sen University

Timeline & Enrollment

Phase 3

Mar 01, 2024

Mar 01, 2031

550 participants

Primary Outcome

Regional relapse-free survival

Summary

To evaluate whether individualized elective neck irradiation for nasopharyngeal carcinoma
 based on the vertebral level of metastatic lymph nodes can reduce the incidence of
 radiation-related adverse effects and improve patients' quality of life๏ผŒwithout reducing
 survival.

ICD-10 Classifications

Malignant neoplasm of nasopharynx
Malignant neoplasm: Nasopharynx, unspecified
Malignant neoplasm: Overlapping lesion of nasopharynx
Benign neoplasm: Nasopharynx
Malignant neoplasm: Posterior wall of nasopharynx

Data Source

ClinicalTrials.gov

NCT06241612

Non-Device Trial